Legacy Financial Group LLC Cybin Inc. Transaction History

Legacy Financial Group LLC

  • $520 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024
BUY
$0.3 - $0.46 $6,799 - $10,426
22,666 New
22,666 $9.37 Million
Q3 2023

Oct 24, 2023
BUY
$0.29 - $0.63 $6,573 - $14,279
22,666 New
22,666 $12,000

Others Institutions Holding CYBN

# of Institutions
11
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Legacy Financial Group LLC Portfolio

Follow Legacy Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email